Boehringer Ingelheim – Startup Investor Profile

Boehringer Ingelheim is a group of pharmaceutical companies that focuses on prescription medicines and animal health.

Location: Ingelheim Am Rhein

Country:

Investment Regions: EU

Investment Stages: late-stage

Website: https://www.boehringer-ingelheim.com/

AI Reasoning: I found a public announcement that Boehringer Ingelheim Venture Fund participated in a Series A investment in Synthetica Pioneering announced on July 30, 2024. The investment date is approximately 15 months before the reference date, which places the last known investment outside the 6-3 month window but within the 12-6 month window? Recalculate: July 30, 2024 to reference is over 15 months, which is more than 12 months, but additional sources (e.g., PitchBook) indicate a later investment on Oct 22, 2025 in Smartbax; however that is after the reference date and cannot be used. Given reliable multiple press reports of the July 30, 2024 Synthetica investment (startup: Synthetica Pioneering) as the latest verifiable public investment within the searched timeframe, the time since last known investment is greater than 12 months, so the correct classification is not-active.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.